| Record ID | marc_loc_2016/BooksAll.2016.part06.utf8:48933063:908 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part06.utf8:48933063:908?format=raw |
LEADER: 00908cam a22002651 4500
001 66006720
003 DLC
005 20050603201232.0
008 760220s1963 xx 000 0 eng
010 $a 66006720
035 $a(OCoLC)2004028
040 $aDLC$cODaU$dMnU-L$dDLC
042 $apremarc
043 $an-cn---
050 00 $aHD9670.C22$bA56
110 1 $aCanada.$bRestrictive Trade Practices Commission.
245 10 $aReport concerning the manufacture, distribution and sale of drugs.$cCombines investigation act.
260 $aOttawa$b[Dept. of Justice]$c1963.
300 $axxv, 572, 290 p.$c25 cm.
490 1 $aIts RTPC$vno. 24
504 $aBibliographical footnotes.
650 0 $aPharmaceutical industry$zCanada.
650 0 $aRestraint of trade$zCanada
740 4 $aThe manufacture, distribution and sale of drugs.
810 1 $aCanada.$bRestrictive Trade Practices Commission.$tRTPC$vno. 24.